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Vibrio vulnificus rpoS Expression Is Repressed by Direct
Binding of cAMP-cAMP Receptor Protein Complex to Its
Two Promoter Regions*□S
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Vibrio vulnificus, a septicemia-causing pathogenic bacte-
rium, acquires resistance against various stresses and
expresses virulence factors via an rpoS gene product. In this
study, we investigated the transcriptional characteristics of
this global regulator. Two distinct transcriptional initiation
sites for the rpoS gene, the proximal promoter (Pp) and the
distal promoter (Pd), were defined by primer extension exper-
iments. Various rpoS::luxAB transcriptional fusions indi-
cated that Pd is a major promoter of rpoS expression.Western
blot analysis showed that RpoS levels were inversely corre-
lated with intracellular levels of 3,5-cyclic AMP (cAMP).
The expressions of both Pd and Pp were increased in cya and
crp mutants. The exogenous addition of cAMP to the cya
mutant resulted in repressed expression of rpoS. In addition,
rpoS expression was significantly lowered in the cpdA
mutant, in which the level of cAMP was elevated because of
the absence of 3,5-cAMP phosphodiesterase. In vitro tran-
scription assays using the V. vulnificus RNA polymerase
showed that the transcripts from both promoters were
reduced by addition of the cAMP-cAMP receptor protein
(CRP). The cAMP-CRP was shown to bind to two rpoS pro-
moters by electrophoretic mobility shift assays. The alter-
ation of the putative CRP-binding site on each rpoS pro-
moter, via site-directed mutagenesis, abolished the binding
of cAMP-CRP as well as regulation by cAMP-CRP. Therefore,
this study shows a relationship between the level of intracel-
lular cAMP and the degree of rpoS expression and further
demonstrates, for the first time, the direct binding of the
cAMP-CRP complex to rpoS upstream regions, which results
in repression of rpoS gene expression.
Global and immediate response to diverse environmental
stimuli is one of the characteristics of bacterial adaptation and
survival. Cellular responses to stressful conditions have been
extensively studied in many bacterial species, most notably in
Escherichia coli (1). To respond properly to diverse stresses,
E. coli requires the rpoS gene product, which is a second prin-
cipal  factor, RpoS (s), to endow it with the ability to mediate
changes in bacterial physiology and structure.Vibrio vulnificus,
a human pathogen causing a fatal septicemia with rapid patho-
genic progression and a highmortality rate (2), has been shown
to require RpoS for better survival under nutrient starvation,
oxidative stress, UV irradiation, and acidic conditions (3, 4).
RpoS is also required for eliciting phenotypes related to vir-
ulence in many pathogenic bacteria belonging to the -subdi-
vision of Proteobacteria (5).V. vulnificus has been shown to use
RpoS to express its major virulence factors, such as an elastase
(6) and other exoproteases (3), and for expression of the fur
gene, which encodes a transcriptional regulator of virulence-
associated iron-uptake systems (7, 8).
Thus, the intracellular level of RpoS needs to be finely
adjusted depending on the environmental conditions, and it is
modulated via transcriptional control of the rpoS gene, transla-
tional efficiency of rpoSmRNA, proteolysis of the RpoS protein,
and the interaction of RpoS with RNA polymerase core sub-
units (1). Transcriptional regulation of rpoS expression has
been shown to bemediated by diverse trans-acting proteins (9).
A transcription factor, ArcA, represses rpoS expression by
binding to the regulatory regions flanking the major promoter
of the E. coli rpoS gene (10). The repressor Fis and the activator
PsrA directly bind to the rpoS gene regulatory regions of Sal-
monella enterica and Pseudomonas spp., respectively (11, 12).
InBorrelia burdorferi, another factor, RpoN, is involved in the
expression of its rpoS gene (13).
The role of cAMP-CRP2 complex as a negative transcrip-
tional regulator in rpoS expression was shown genetically using
crp, cya, and crr knock-out mutants of E. coli and other bacte-
rial species (14, 15). However, whether control by cAMP-CRP
complex is direct or indirect has not yet been determined,
because the effects of cAMP-CRP on rpoS expression were
shown only by transcriptional fusion assays, and direct evi-
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dence for the binding of cAMP-CRP complex to rpoS promoter
regions and the effect of cAMP-CRP on rpoS transcription have
not been reported in any bacterial species (1, 16). In addition,
the locations of the putative CRP-binding sites of E. coli rpoS
were predicted to be the sites centered at61.5 and56.5 with
respect to the major transcription start site. Because the CRP-
binding sites usually overlap with the promoters of the genes
repressed by the cAMP-CRP complex, those putative CRP-
binding sites are not typical for a negative regulation; one (cen-
tered at61.5) is usually an activating site and the other (cen-
tered at56.5) is located at the downstream region of the rpoS
initiation codon (IC) (1, 10). Thus, the molecular basis of how
the cAMP-CRP complex modulates the transcription of the
rpoS gene has not been completely defined.
We have previously isolated the rpoS homolog fromV. vulni-
ficus (17) and characterized the roles of RpoS in bacterial
response to various environmental conditions, which bacteria
might encounter within a host (4, 6, 7). Although the functions
of RpoS are quite conserved in diverse bacteria, the regulatory
modes of rpoS gene transcription are distinct in each bacterium
(9). Therefore, we are interested in the transcriptional charac-
teristics of V. vulnificus rpoS. In this study, we defined two
distinct promoters for the V. vulnificus rpoS gene and demon-
strated direct evidence for transcriptional regulation of rpoS via
the interaction of the cAMP-CRP complex with these two
promoters.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, andCulture Cultivation—Bacterial strains
and plasmids used for this study are listed in Table 1. E. coli
strains used for plasmid DNA preparation and conjugational
transfer were grown in Luria-Bertani (LB) broth or on LB plates
containing 1.5% (w/v) agar. V. vulnificus strains were grown in
LB medium supplemented with additional 2% (w/v) NaCl
(LBS), unless stated otherwise. All medium components were
purchased fromDifco, and chemicals and antibiotics were pur-
chased from Sigma.
Primer Extension Experiment—An oligonucleotide, PE83
(Table 2), complementary to the open reading frame (ORF) of
rpoSwas end-labeled with [-32P]ATP using T4 polynucleotide
kinase and then used for cDNA synthesis. RNA was converted
to cDNAwith SuperScript II reverse transcriptase (Invitrogen).
The resultant cDNA products were purified and resolved on a
sequencing gel alongside sequencing ladders generated with
the same primer used for primer extension. The nucleotide
sequence of pINE32 was determined using the dideoxy chain
terminationmethodwithTopTMDNApolymerase (Bioneer) as
described previously (18). The sequencing gels were dried and
then visualized upon exposure to a PhosphorImager (Personal
Molecular Imager FX, Bio-Rad). Another oligonucleotide,
PE-368 (Table 2), was used for synthesis of cDNA to examine
rpoS expression derived from the second promoter as described
above.
TABLE 1
Bacterial strains and plasmids used in this study
TABLE 2
Oligonucleotides used in this studya
a Restriction sites are underlined and their usages in cloning experiments are
described under “Experimental Procedures.”
bModified nucleotides for site-directed mutagenesis are italicized and the detailed
information is described in the text.
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Construction of the cpdA V. vulnificus Strain, HY101—A
762-bp cpdA upstream region was amplified using primers
cpd5F and cpd5R (Table 2), which locate at 784 and 27
relative to the cpdA IC, respectively. The resultant PCRproduct
was digested with the appropriate restriction enzymes, SpeI
and BglII, and ligated to a suicide vector pDM4 treated with the
same enzymes (19) to produce pHY01. A 449-bp DNA frag-
ment was amplified using primers icc3F and icc3R (Table 2),
which are located at302 and750 relative to the IC of cpdA,
respectively. This PCR product was digested with BglII and
SphI and cloned into pHY01, resulting in pHY02. Finally, a
1.2-kb kanamycin resistance gene, isolated by digesting pUC4K
(GEHealthcare) with BamHI, was inserted into the BglII site of
pHY02 to yield pHY03. Plasmid pHY03 in the SM10 pir (20)
strain was mobilized to V. vulnificus AR, a rifampin-resistant
derivative strain of V. vulnificus ATCC29307, and the conju-
gates were selected by plating the mixture of E. coli and V.
vulnificus onLBS supplementedwith 4g/ml chloramphenicol
and 50g/ml rifampin. A colonywith characteristics indicating
a double homologous recombination event (resistance to 5%
(w/v) sucrose, sensitivity to chloramphenicol, and resistance to
kanamycin) was further confirmed by PCR, using primers
cpd5F and icc3R, and named HY101.
Construction of cya V. vulnificus Strain, KP301—A
3,245-bp DNA fragment containing the cya ORF and its
upstream and downstream regions was amplified from the
genomic DNA of V. vulnificus ATCC29307 using two primers,
cya-F and cya-R (Table 2). The PCR product was digested with
ApaI and XbaI and then cloned into pBluescript II SK() to
produce pVVcya. Amutation in cyawas created by deleting the
NsiI fragment within the cya coding region in pVVcya, thus
yielding pVVcya. A 1,973-bp DNA fragment of pVVcya
digested with ApaI and XbaI was ligated into a suicide vector,
pDM4, to generate pDMcya. The E. coli SM10 pir strain car-
rying pDMcya was conjugated to V. vulnificus ATCC29307,
and the exconjugants were then selected on thiosulfate citrate
bile sucrose medium supplemented with 4 g/ml chloram-
phenicol. A colony indicating double homologous recombina-
tionwas confirmed by PCR, using primers cya-F and cya-R, and
named KP301.
Construction of rpoS luxAB Transcriptional Fusions—A set
of rpoS::luxAB transcriptional fusions was made by subcloning
a series of rpoS promoter DNA fragments into pHK0011 (6).
Primer rpoS88 (Table 2) contained an XbaI restriction site
followed by bases corresponding to the 5-end of the rpoS cod-
ing region. Primer rpoS88 was used in conjunction with one
of the following primers to amplify DNA upstream of rpoS:
rpoS-105 (for pKP-105), rpoS-368 (for pKP-368), rpoS-732 (for
pKP-732), rpoS-891 (for pKP-891), rpoS-1315 (for pKP-1315),
and rpoS-1640 (for pKP-1640) (Tables 1 and 2). The PCR prod-
ucts were digestedwith BamHI andXbaI and then inserted into
pHK0011, which had been digested with the same enzymes, to
create six different rpoS::luxAB fusions.
Luciferase Assay—The rpoS::luxAB reporters weremobilized
into wild type, cpdA, crp, and cya V. vulnificus mutants via
conjugal transfer. Overnight (16–18 h) cultures of the bacterial
cells containing one of these fusions were inoculated into fresh
LBSmedium containing tetracycline (3g/ml) and then grown
to the stationary phase. At various time points of bacterial
growth, a portion of the samples was taken from each culture
and diluted 100-fold with LBS medium. The expression from
various lengths of the rpoS promoter was measured by moni-
toring light production in the presence of 0.006% (v/v) n-decyl
aldehyde using a luminometer (TD-20/20; Turners Designs).
Light production was expressed in arbitrary relative light units
(RLU), and the specific bioluminescence was calculated by nor-
malizing RLUwith cell mass (A595), as described previously (7).
cAMP at a concentration of 0.5 mM was added exogenously to
the culture ofcyamutantV. vulnificus either with pKP-368 or
pKP-1315, and the light emission from these cells was moni-
tored at the various phases of bacterial growth.
Western Blot Analysis—The plasmid pQErpoS was con-
structed to express the recombinant RpoS protein as a histi-
dine-tagged form, which was then used to produce polyclonal
antibodies against V. vulnificus RpoS as described previously
(4). Wild type V. vulnificus was harvested at various phases of
bacterial growth in LBS broth, and bacterial extracts were then
prepared by sonication in TNT buffer (10 mM Tris-HCl, 150
mMNaCl, and 0.05% (v/v) Tween 20, pH 8.0) (21). Forty micro-
grams of the extracts were fractionated by SDS-PAGE. After a
transfer to a Hybond P membrane (Amersham Biosciences),
Western blot analysis was performed by serially incubating the
filter with anti-V. vulnificusRpoS antibodies (1:5,000) and alka-
line phosphatase-conjugated rabbit anti-rat immunoglobulinG
(1:5,000; Sigma). The RpoS protein of V. vulnificus was visual-
ized using an nitro blue tetrazolium-5-bromo-4-chloro-3-in-
dolyl phosphate system (Promega). To investigate the role of
cAMP-CRP in RpoS formation, cell extracts of wild type, crp,
cya, and cpdAmutant V. vulnificus were prepared and then
examined byWestern blot analysis with RpoS-specific antibod-
ies. cAMP was added to the cya mutant at a final concentra-
tion of 0.5 mM, and the bacterial extract was also prepared for
Western blot analysis.
Purification of V. vulnificus RNAPolymerase (RNAP)Coreen-
zyme and  Factor 70 (RpoD)—V. vulnificus MO6–24/O was
grown in LBS medium at 30 °C for 6 h. Cell pellet was resus-
pended in the cold grinding buffer (50 mM Tris, 5% (v/v) glyc-
erol, 2 mM EDTA, 233 mM NaCl, 1 mg/ml lysozyme, 1 mM
phenylmethylsulfonyl fluoride, 0.5mMdithiothreitol, and 7mM
-mercaptoethanol, pH 8.0). After 20 min of incubation on ice,
the bacterial cells were disrupted by sonication in the presence
of 4% (w/v) sodium deoxycholate. The core RNAP was purified
by an immunoaffinity chromatography using the polyol-re-
sponsive monoclonal antibody 8RB13 (NeoClone Biotechnol-
ogy) as described (22, 23). Eluted core RNAP was then dialyzed
with the storage buffer (50mMTris-HCl, 0.1mMEDTA, 0.1mM
dithiothreitol, 50% (v/v) glycerol, pH 7.6). The coding region of
V. vulnificus rpoDwas amplified using oligonucleotide primers,
F-rpoDvv andR-rpoDvv (Table 2). The 1.8-kbPCRproductwas
digested with NdeI and XhoI and then ligated to the expression
vector, pET28a (Novagen), which was digested with the same
enzymes, to produce pSH0505. His-tagged recombinant RpoD
protein was expressed in E. coli BL21 in the presence of 1.0 mM
isopropyl thio--D-galactoside and then purified by a nickel-
nitrilotriacetic acid affinity chromatography according to the
manufacturer’s procedure (Qiagen).
Direct Binding of cAMP-CRP to rpoS Promoters
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In Vitro Transcription Assay in the Presence of CRP—The
plasmids containing the templates for RNAP were constructed
by inserting the DNA fragments of rpoS promoter regions to
pRLG770 (24). The insert DNA, including rpoS Pd, was ampli-
fied using the PCR primers rpoS-IV-1 and rpoS-IV-2. The
insert DNA, including rpoS Pp, was amplified using rpoS-IV-3
and rpoS-IV-5 (Table 2). Amplified DNA were digested with
EcoRI and HindIII and then ligated to EcoRI/HindIII-treated
pRLG770. Purified CRP (0, 72, 144, 216, and 288 nM) and the
plasmid (0.25 nM) were mixed in the reaction buffer (50 mM
KCl, 20 mM Tris-HCl, 3 mM MgCl2, 0.1 mM dithiothreitol, 0.1
mMEDTA, 0.5mM cAMP, pH 8.0) and incubated at 37 °C for 40
min. The radiolabeled nucleotide (5 Ci of [-32P]UTP) and
cold nucleotides (25 M UTP and 500 M each ATP, CTP, and
GTP)were added to the reactionmixture, and the transcription
was initiated by adding the V. vulnificus RNAP holoenzyme
premixture of 10 nM core RNAP and 10 nM RpoD (supplemen-
tal Fig. 1). The in vitro transcription reactions were stopped
with the stop buffer (95% formamide, 20 mM EDTA, 0.05%
bromphenol blue, and 0.05% xylene cyanol, pH 8.0) after 15
min. The reaction mixtures were electrophoresed on a 6.5%
polyacrylamide/bisacrylamide (19:1), 7 M urea denaturing gel.
Transcripts were visualized and quantified using Personal
Molecular Imager FX and Quantity One software, respectively
(Bio-Rad).
Electrophoretic Mobility Shift Assay—V. vulnificus recombi-
nant CRP protein was overexpressed in E. coli BL21 carrying
pHK0201 (25), a pRSETA (Invitrogen)-based expression plas-
mid, and purified by a nickel-nitrilotriacetic acid affinity chro-
matography according to the manufacturer’s procedure
(Qiagen).The 394-bp upstream region of the rpoS gene, extend-
ing from residues732 to339 with respect to the IC of rpoS,
was amplified by PCR using 32P-labeled PE-368 and unlabeled
rpoS-732 as primers (Table 2). The other rpoS promoter region
used for binding assays wasmadewith two primers, PE83 and
rpoS-368 (Table 2), which contained the 456-bpDNA fragment
from373 to83 with respect to the IC of rpoS. Seven nano-
molar of the labeled DNA fragment was incubated with varying
concentrations of purified histidine-tagged CRP protein (150–
600 nM) for 30min at 37 °C in a 20-l reactionmixture contain-
ing 1 binding buffer (26), including 500 M cAMP (Sigma).
Following the addition of 3l of loading buffer to each reaction,
the samples were separated by electrophoresis on a 6% nonde-
naturing polyacrylamide gel. For competition analyses, the
identical but unlabeled rpoS DNA fragment was included as a
competitorDNA.Various amounts of competitorDNA (14–70
nM) were added to the reaction mixture containing 7 nM of the
labeled DNA prior to the addition of 600 nM CRP. A 378-bp
DNA fragment encompassing the promoter region of the gap
gene encoding glyceraldehyde-3-phosphate dehydrogenase
was amplified from genomic DNA of V. vulnificus using prim-
ers gap-F and gap-R (Table 2) and included as nonspecific DNA
in the binding assay.
cAMP Assay—V. vulnificus cells grown in LBS were har-
vested, and the amounts of cAMP in the bacterial lysates were
estimated according to the manufacturer’s instructions (cAMP
Biotrak EIA System, Amersham Biosciences).
Site-directed Mutagenesis of the rpoS Promoters—The puta-
tive CRP-binding sites include the sequences homologous to
the inverted repeat, TGTGAN6TCACA. Inverted repeats,
which are located at26 to47 relative to the distal transcrip-
tion initiation site (CRP-binding site I) and27 to48 relative
to the proximal transcription initiation site (CRP-binding site
II) of the rpoS gene, were mutagenized using primers carrying
the substituted nucleotides. To amplify themutatedCRP-bind-
ing site I, two sets of primers, rpoS-1315/rpoSM1-R and
rpoSM1-F/rpoS88 (Table 2), were utilized. Two PCR prod-
ucts (an 846-bp PCR product using rpoS-1315 and rpoSM1-R
and a 584-bp PCRproduct using rpoSM1-F and rpoS88) were
used as template DNAs to produce themutagenized rpoSDNA
fragment, encompassing the segment from1315 and88 rel-
ative to the IC of rpoS, using primers rpoS-1315 and rpoS88.
The resultant mutagenized rpoS promoter DNA was cloned
into the pGEM-T Easy vector (Promega) to produce pGEMT-
rpoSmt1. To amplify the mutated CRP-binding site II, two
primer sets, rpoS-368/rpoSM2-R and rpoSM2-F/rpoS88,
were used. Two PCR products (a 345-bp PCR product using
rpoS-368 and rpoSM2-R, and a 142-bp PCR product using
rpoSM2-F and rpoS88) were used as template DNAs to pro-
duce the mutagenized rpoS DNA fragment, encompassing the
segment from 368 and 88 relative to the IC of rpoS, using
primers rpoS-368 and rpoS88. The resultant mutagenized
rpoS promoter DNAwas cloned into the pGEM-T Easy vector
(Promega) to produce pGEMT-rpoSmt2. The mutagenized
nucleotide sequences of both pGEMT-rpoSmt1 and pGEMT-
rpoSmt2 were confirmed by DNA sequencing. Then the insert
DNA fragment of each plasmid, digestedwith BamHI andXbaI,
was ligated to BamHI/XbaI-digested pHK0011, which con-
tained the promoterless luxAB genes. The resultant plasmids,
prpoSM1 and prpoSM2, were mobilized into V. vulnificus
strains by conjugation, and the exconjugants were selected in
thiosulfate citrate bile sucrose medium supplemented with 3
g/ml tetracycline.
Statistical Analyses—Results were expressed as the means
S.D. from at least three independent experiments. Statistical
analysis was performed using the Student’s t test (SYSTATpro-
gram, SigmaPlot version 9, Systat Software Inc.). Differences
were considered significant at p values0.01.
Nucleotide Sequence Accession Numbers—The nucleotide
sequences of the cpdA and cya genes isolated fromV. vulnificus
ATCC29307 have been deposited in the GenBankTM data base
under the accession numbers AY221025 and AY240931,
respectively.
RESULTS
Identification of Two Transcription Start Sites of the V. vulni-
ficus rpoS Gene—RNAprepared from the stationary phase cells
was converted to cDNA using primer PE83, which annealed
to the nucleotide sequences between 54 and 83 relative to
the IC of rpoS. Upon gel electrophoresis with the sequencing
ladder of the rpoS genewith the same primer, a single signal was
observed 29 bp upstreamof the IC of RpoS (Fig. 1A), which is 52
bp downstream of the stop codon of the adjacent gene, nlpD.
Putative10 (TAAAGT) and35 (TTGCGA) sequences were
Direct Binding of cAMP-CRP to rpoS Promoters
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discernable, and this promoter was designated as Pp, a pro-
moter proximal to the rpoSORF (Fig. 1C).
The same RNA was hybridized with another primer PE-368,
which contained complementary sequences to nucleotide
sequences between368 and339, relative to the IC of rpoS.
The initiation site of the resultant cDNA was mapped at473
with respect to the IC of rpoS (Fig. 1B). This putative promoter
resided within the ORF of the upstream gene, nlpD, with rea-
sonable promoter sequences (CTGTCA and AATAAC as35
and10, respectively), andwas des-
ignated as Pd, a distal promoter to
the rpoSORF (Fig. 1C).
Expressional Analysis of rpoS Pro-
moters Using luxAB-transcriptional
Fusions—A series of luxAB-tran-
scriptional fusions were con-
structed by cloning various lengths
of the rpoS promoter regions (Fig.
2A). Two rpoS::luxAB fusions, pKP-
105 and pKP-368, contained only
the Pp, whereas the remaining four
fusions with longer promoter
regions had both promoters Pd and
Pp. During growth, the expressions
of these diverse fusions were deter-
mined by measuring their luciferase
activities (Fig. 2B). The basal and
induced expression levels of
pKP-105 were similar to those of
pKP-368. The remaining four lon-
ger fusions (pKP-732, -891, -1315,
and -1640) also showed similar lev-
els of expression compared with
each other, but significantly higher
expression (over 200-fold) relative
to the other two shorter fusions,
including only Pp. When bacterial
cells entered the stationary phase,
the shorter fusions were induced
about 3–4-fold, and the longer
fusions were induced 12–15-fold.
For further analyses, pKP-368 was
chosen to represent the expression
from Pp only, and pKP-1315 was
chosen to represent the expression
from both Pd and Pp.
Intracellular Levels of RpoS and
cAMP during V. vulnificus Growth—
Using polyclonal antibodies specific
to V. vulnificus RpoS, intracellular
levels of RpoS were measured at
various time points along a growth
curve (Fig. 3). Upon Western blot
analysis with RpoS-specific anti-
bodies, an immunoreactive band
of 40 kDa was observed in eight
different bacterial extracts along
the growth curve. The intensity of
this band became stronger as the cells entered the stationary
phase, as shown by the assay using luxAB-transcriptional
fusions. Densitometric quantification of these immunoreac-
tive bands indicates about a 5-fold increase in the RpoS level
as bacterial cells entered the stationary phase in LBS
medium.
The observation that transcription of the rpoS gene and the
amount of RpoS increased at the stationary phase suggests the
presence of some intracellular signal(s) that switched on the rpoS
FIGURE 1. Identification of the transcriptional start sites of the rpoS gene in V. vulnificus. A, primer exten-
sion experiment using V. vulnificus RNA and the oligonucleotide primer PE83 (annealing to the region from
54 to 83 relative to the IC of rpoS). Lanes C, T, A, and G represent the nucleotide sequencing ladders of
pINE32. Theasterisk indicates the siteof transcriptional initiation for rpoS.B, primer extensionexperimentusing
the oligonucleotide primer PE-368 (annealing to the region from 368 to 339 relative to IC) as described
above.C, two rpoSpromoters in thenlpDopen reading frame andnlpD-rpoS intergenic space. Thepromoter Pp
is proximal to the IC of rpoS, and the promoter Pd is distal from the IC of rpoS. The promoters,10 and35
regions, are underlined, whereas the stop codon of nlpD and the start codon of rpoS are capitalized.
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expression system. The most probable signals related to the
high cell density or stationary phase conditions are quorum-
sensing signal molecules and cAMP, as suggested previously
(27–29). The luxS mutant V. vulnificus, which is defective in
production of the autoinducer-2 (30), showed similar levels of
RpoS to the wild type (supplemental Fig. 2). cAMP levels were
also estimated from the bacterial cells grown under the same
incubation condition used for Western blot analysis (Fig. 3). V.
vulnificus grown exponentially in the complexmedium, such as
salt-enriched LB broth, contained 20–50 fmol of cAMP/g of
bacterial protein. When V. vulnificus entered the stationary
phase, its intracellular cAMP contents dramatically decreased
to the levels less than 5 fmol of cAMP/g of bacterial protein.
This result suggests an inverse correlation between cAMP con-
centration and rpoS expression.
Effect of cAMP-CRP on rpoS Expression—The inverse rela-
tionship between cAMP contents and rpoS expression implied
that cAMP and CRP might repress rpoS gene expression. To
FIGURE 2.Deletion analysis of the regulatory region of rpoS. A, construction of rpoS::luxAB fusion plasmids. PCR fragments carrying different lengths of the
upstream region of rpoS were cloned into pHK0011 to create various transcriptional reporter luxAB fusions. Two promoters, defined by primer extension
analyses, are indicated as Pd and Pp. B, expression of rpoS::luxAB fusions. Wild type V. vulnificus carrying one of the six rpoS::luxAB fusions was grown in LBS
medium supplementedwith 3g/ml tetracycline and examined for luminescence as they grew (open circles). Luciferase activities are expressed as normalized
values (closed circles): number of relative light units (RLU) divided by the A595 value of each sample.
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test this hypothesis, two representative rpoS::luxAB fusions
(pKP-368 and pKP-1315) were transferred to two mutant V.
vulnificus strains, deficient in either cya (coding for the cAMP-
synthesizing enzyme, adenylate cyclase) or crp (coding for
cAMP-receptor protein). Both fusions in crp or cya mutant
strains showed about a 3-fold increase in their expression over
that of the wild type strain (Table 3). Exogenous addition of
cAMP (0.5 mM) to the cyamutant reduced the expression of
both fusions to wild type levels. In addition, another V. vulnifi-
cus mutant, which is deficient in the cpdA gene encoding a
3,5-cAMP phosphodiesterase, showed an even lower expres-
sion of both fusions compared with the wild type strain.
Cellular levels of RpoS proteins in crp and cya V. vulnificus
mutants were also compared with that of the wild type isogenic
strain (Fig. 4). In Western blot analysis using polyclonal anti-
bodies against recombinant RpoS of V. vulnificus, more RpoS
proteins were observed in both crp andcya strains than in the
wild type. The cya strain grown in the presence of exog-
enously added cAMP demonstrated a decreased level of RpoS.
We then reconstituted theCRP-dependent repression of two
rpoS promoters in vitro. The upstream regions of two rpoS pro-
moters, Pd and Pp, were cloned into pRLG770 to produce
prpoS-Pd and prpoS-Pp, respectively. In vitro transcription
reaction with each plasmid DNA in the presence of core RNAP
and RpoD of V. vulnificus produced two discrete transcripts,
the plasmid-encoded RNA-1 (108 nucleotides long) and the
longer transcript (188 nucleotides long RNA from prpoS-Pd or
210 nucleotides long RNA from prpoS-Pp) (Fig. 5). The results
of in vitro transcription assays showed that cAMP-CRP has
little or no effect on the synthesis of RNA-1 but repressed syn-
theses of the transcripts from the Pd and Pp promoters (Fig. 5,A
and B). Effect of cAMP-CRP complex on transcription repres-
sion of Pp was more pronounced than that of Pd, because the
slope of the decrease in relative intensities of rpoS Pp transcript
was steeper than that of rpoS Pd transcript over the CRP con-
centration range used (Fig. 5, C and D). rpoS Pp transcript was
not produced in the presence ofmore than 200 nMCRP. On the
other hand, production of rpoS Pd transcript was less sensitive
to CRP concentration. About 50% of the rpoS Pd transcript
production was repressed in the presence of	200 nM CRP.
Specific Binding of cAMP-CRP Complex to the rpoS
Promoters—This study clearly demonstrated that cAMP and
CRP negatively affect the expression of rpoS. To determine
whether the cAMP-CRP complex acts directly by binding to the
rpoS promoter regions, we performed an electrophoretic
mobility shift assay (EMSA)usingV. vulnificusCRPprotein and
two different DNA fragments containing Pd or Pp. As shown in
Fig. 6A, the addition of CRP and cAMP resulted in a shift of the
456-bp Pp DNA fragments to a band with slower mobility.
Binding of cAMP-CRP to the Pp DNA was specific, because
formation of the slower moving band was abolished by includ-
ing excess unlabeled Pp DNA in the reaction mixture, but it
retained its retarded mobility in the presence of a DNA frag-
ment unrelated to the rpoS promoter sequence, such as the V.
vulnficus gap promoter.
For another set of EMSA with cAMP-CRP, a 394-bp DNA
containing Pdwas used as a probe (Fig. 6B).When the labeledPd
DNAwas incubated with cAMP-CRP, formation of the cAMP-
CRP-DNA complex was detected as a slower moving DNA
band. The specificity of cAMP-CRP binding to this DNA was
also confirmed by competition experiments, in which excess
unlabeled 394-bp Pd DNA competed out the binding of cAMP-
CRP to the 32P-labeled PdDNA in a dose-dependentmanner. In
contrast, inclusion of nonspecific gap promoter DNA in the
binding assays did not disrupt the CRP-Pd DNA interaction.
FIGURE 3. Intracellular levels of cAMP and RpoS at various growth stages
of V. vulnificus. V. vulnificus cells grown in LBS were assayed for cAMP using
the cAMP Biotrak enzyme immunoassay system (Amersham Biosciences),
and presented as femtomoles of cAMP perg of bacterial protein (circles). At
various time points of bacterial growth (designated by numbers from 1 to 8),
cells were harvested and then subjected to Western blot analysis (lower
panel). The intensities of bands corresponding to RpoS were estimated by
densitometry and are also presented in the plot (triangles).
FIGURE 4. Effect of cAMP and CRP on the intracellular level of RpoS pro-
tein. Extracts of various V. vulnificus strains, which were grown to the early
stationary phase (A595 of 1.0–1.5), were subjected to Western blot analysis
usingpolyclonal antibodies againstV. vulnificusRpoS. Lane1,wild type; lane2,
crpmutant; lane 3, cyamutant; and lane 4, cyamutant grown in the pres-
ence of exogenously added cAMP (0.5 mM).
TABLE 3
Expression of rpoS::luxAB fusions in various genetic backgrounds
Genetic
background
Intracellular
cAMP levela
Expression of
luxAB-transcriptional
fusion (RLU/OD)b
pKP-368 pKP-1315
fmol/g protein
Wild type 8.4 1,320 86 267,780 1,450
crp 421 3,430 95 739,960 87,700
cya Not detectablec 3,130 26 632,590 17,900
cya cAMP
(0.5 mM)
ndd 1,110 9 219,540 9,080
cpdA 24 590 16 119,480 4,610
a cAMP contents were measured from the stationary phase V. vulnificus, and its
levels were expressed as moles of cAMP in the unit mass of bacterial cells (deter-
mined by protein amount in lysate).
b RLU per cell mass determined by A595.
c cAMP concentration was below the detection limit of the assay used in this study.
dNDmeans not determined.
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The apparent affinity of cAMP-CRP complex to each rpoS pro-
moter was compared by extrapolating the CRP concentration
required for 50% binding of the labeled DNA (Fig. 6C). The
dissociation binding constants (Kd) for CRP to Pp and Pd were
250 and 410 nM, respectively. Thus, the results from both the
in vitro transcription assays (Fig. 5) and EMSA (Fig. 6) suggest
that the promoter Pp has higher affinity to cAMP-CRP
complex.
Effect of Mutation of the Putative CRP-binding Sites on Bind-
ing of CRP and Expression of rpoS—The nucleotide sequences
of the two rpoS promoters were analyzed to determine whether
they include the putative cAMP-CRP binding sequence. Nucle-
otide sequences of both promoters showed considerable
homology to the consensus sequence for the E. coli cAMP-
CRP-binding site (AAATGTGATCTAGATCACATTT; see
Ref. 31) at the upstream regions including their 35 regions
(Fig. 7A). To verify if cAMP-CRP binding to these putative sites
occurs and to determine whether these interactions are impor-
tant in rpoS transcription from Pd and Pp, the putative binding
sites were modified by site-directed mutagenesis. The DNA
fragments containing the mutagenized nucleotide sequences
(mt probes) were then used for electrophoretic mobility shift
assays. No binding of cAMP-CRP to mt probes was observed
(Fig. 7, B andC, lanes 3–6), although the amount of CRP added
to the binding assay was two times (up to 765 nM CRP) more
than that of the original nucleotide sequences (wild type
probes) (Fig. 7, B and C, lane 2).
In addition, the mutagenized DNAs were used to construct
the luxAB -transcriptional fusions, pKP-368mt and pKP-
1315mt, which are basically the same as pKP-368 and pKP-
1315, but include the mutated CRP-binding sites. These
mutant fusions in the wild type strain showed derepressed lev-
els of expression (Fig. 7, D and E), which were similar to the
expression levels of pKP-368 and pKP-1315 in the crp andcya
strains. These results suggest that rpoS expression from Pd and
Pp is repressed by direct binding of cAMP-CRP to the regions of
FIGURE 5. Repression of rpoS transcription by the cAMP-CRP complex. A, in vitro transcription at the rpoS promoter Pp in the presence of cAMP-CRP. The
pRLG770 (24)-basedplasmid carrying the rpoSPp (prpoS-Pp)wasused for a template for coreRNAP, RpoD, andCRPderived fromV. vulnificus (supplemental Fig.
1). Produced 32P-labeled transcriptswere separatedon6.5%polyacrylamide/bisacrylamide (19:1), 7Mureadenaturinggel showing twoRNAbands (the control
RNA of 108-nucleotide-long RNA-1 and the 210-nucleotide-long rpoS RNA) on each lane. Lane 1, pRLG770 (no rpoS promoter); lanes 2–6, prpoS-Pp incubated
with 0, 72, 144, 216, or 288 nM of CRP. B, in vitro transcription at the rpoS promoter Pd in the presence of cAMP-CRP. The pRLG770 (24)-based plasmid carrying
the rpoS Pd (prpoS-Pd) was used for an assay, which resulted in production of RNA-1 and 188-nucleotide-long rpoS RNA. Lane 1, pRLG770; lanes 2–6, prpoS-Pd
incubatedwith 0, 72, 144, 216, or 288nMofCRP.C andD,plots illustrating the relative intensity of rpoS transcript. The intensities of twoRNAbandsoneach lane,
the 108-base RNA-1 transcript, and the longer transcript starting from one of the rpoS promoters were estimated by densitometric reading (the plot C is from
A, and the plot D is from the B), and then each rpoS transcript was normalized to RNA-1 on the same lane. Relative intensity of the normalized rpoS transcript
was indicated as the percentage of that in the absence of CRP.
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FIGURE 6. Specific binding of the cAMP-CRP complex to the rpoS promoters. A, binding assay of CRP to the rpoS promoter carrying Pp. The 456-bp
DNA fragment of the rpoS upstream region (Pp) was radiolabeled and incubated, with increasing amounts of CRP up to 600 nM. The identical but
unlabeled competitor DNA fragment was included in the reaction mixtures in various amounts. Lane 1, probe DNA alone; lanes 2–6, probe DNA
incubated with 150, 225, 300, 450, or 600 nM CRP, respectively; lane 7, probe DNA incubated with 600 nM CRP and 14 nM of the identical but unlabeled
DNA; lane 8, probe DNA incubated with 600 nM CRP and 70 nM of the identical but unlabeled DNA; and lane 9, probe DNA incubated with 600 nM CRP and
70 nM gap promoter DNA. The arrows on the left side indicate the unbound DNA probe, whereas the arrows on the right side indicate DNA bound to CRP.
B, binding assay of CRP to the rpoS promoter carrying Pd. Labeled Pd DNA was incubated with increasing amounts of CRP. For competition analysis, the
identical but unlabeled 394-bp DNA fragment was included in the binding reactions containing 600 nM CRP. Lane 1, probe DNA alone; lanes 2–6, probe
DNA incubated with 150, 225, 300, 450, or 600 nM CRP, respectively; lane 7, probe DNA incubated with 600 nM CRP and 14 nM of the identical but
unlabeled DNA; lane 8, probe DNA incubated with 600 nM CRP and 70 nM of the identical but unlabeled DNA; and lane 9, probe DNA incubated with 600
nM CRP and 70 nM nonspecific gap promoter DNA. The arrows on the left side indicate unbound DNA probe, whereas the arrows on the right side indicate
the DNA bound to CRP. C, plot showing the affinity of cAMP-CRP to each promoter of rpoS. The intensities of bound DNA fragments, Pp (open circle) and
Pd (closed circle), were estimated by densitometer and plotted against the CRP concentrations. Arrows indicate the concentrations of CRP causing
half-maximal binding corresponding to the Kd.
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FIGURE 7. Effect ofmutation of the putative CRP-binding sites on CRPbinding and rpoS regulation. A, presence of the putative CRP-binding sites in each
promoter region of the rpoS gene. Two promoters for the rpoS gene are indicated as Pp and Pd alongwith their10 and35 regions (CRP-binding site I in the
Pd promoter and CRP-binding site II in the Pp promoter). Putative CRP-binding sites are presented in the boxes implied from the conserved nucleotide
sequences for CRP binding indicated by italicized letters above the V. vulnificus DNA sequence. Site-directed mutagenized nucleotides in the mutant rpoS
promoters are indicated with arrows. B, binding assay of CRP to the rpoS promoter carrying Pd and mutagenized Pd. Labeled Pd (wild type probe) and
mutagenized Pd DNA (mt probe) were incubated with CRP, as described in Fig. 5. Lane 1, Pd DNAwithout CRP; lane 2, Pd with 340 nM CRP; lane 3, mutagenized
Pd without CRP; lanes 4–6, mutagenized Pd with 340, 510, and 765 nM CRP, respectively. The arrows on the left side indicate the unbound DNA probe, whereas
the arrows on the right side indicate the DNA bound to CRP. C, binding assay of CRP to the rpoS promoter carrying Pp andmutagenized Pp. Labeled Pp (wild type
probe) and mutagenized Pp DNA (mt probe) were incubated with increasing amounts of CRP. Lane 1, Pp DNA without CRP; lane 2, Pp with 340 nM CRP; lane 3,
mutagenized Pp without CRP; lanes 4–6, mutagenized Pp with 340, 510, and 765 nM, CRP, respectively. The arrows on the left side indicate unbound DNA probe,
whereas the arrows on the right side indicate theDNAbound to CRP.D and E, effect ofmutation on the expression of rpoS::luxAB transcriptional fusions.Wild type V.
vulnificus carrying pKP-368 or pKP-368mt (pKP-368 including themutated CRP-binding site II) andwild type carrying pKP-1315 or pKP-1315mt (pKP-1315, including
themutatedCRP-bindingsite I)weregrowninLBSmediumsupplementedwith3g/mltetracycline,andtheir luciferaseactivitiesweremeasured.Luciferaseactivities
are expressed as normalized values: the number of RLU divided by the A595 value of each sample. Datawith p values of0.01 are indicatedwith an asterisk.
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26 to47 relative to Pd (CRP-binding site I) and27 to48
relative to Pp (CRP-binding site II) (Fig. 7A).
DISCUSSION
V. vulnificus is a normal inhabitant of marine estuarine envi-
ronments and can be delivered into humans via ingestion of
seafood or contact with seawater, whereupon it may cause fatal
septicemia or gastroenteritis (2). Thus, this bacterium is
expected to use efficient survival strategies to sense fluctuations
in its surrounding conditions and to express the necessary
defense elements against given stresses. In a previous investiga-
tion, we identified RpoS as a key regulator mediating the sur-
vival ofV. vulnificus (4), as found in other bacteria. Variation of
the intracellular levels of this global transcription factor, under
certain conditions, is critical for modulating the expression of
target genes in a finely coordinated manner.
Modulation of the amount of RpoS, which has been exten-
sively investigated, is achieved by several levels of controls,
including the regulation of transcription, translation, and pro-
teolysis (1). In E. coli, one of the major regulatory mechanisms
modulating the level of RpoS operates at the post-translational
level via an RpoS-specific chaperone/protease system, ClpXP
(32). Under glucose-starved conditions or in the exponential
stage, a recognition factor, RssB, binds to the RpoS protein and
enhances RpoS degradation by recruiting ClpXP to the RssB-
RpoS complex (33). Translation of E. coli rpoS mRNA is regu-
lated by small noncoding RNAs (34). A specific secondary
structure in the rpoS mRNA, which inhibits efficient transla-
tional progress, is disrupted by being paired with DsrA RNA
with the help of an RNA chaperon, Hfq, resulting in increased
translation of rpoSmRNA (35). Similarly, V. vulnificus also uti-
lizes some of the above regulatory
mechanisms, both at the post-tran-
scriptional and the post-transla-
tional levels via Hfq and ClpX,
respectively. For example, the levels
of RpoS, determined by Western
blot analysis, were significantly
reduced in the hfq V. vulnificus
mutant (36) and highly elevated in
the clpX V. vulnificus mutant
(supplemental Fig. 3).
The regulation of E. coli rpoS ex-
pression at the transcriptional level
includes complex mechanisms.
Trans-acting factors involved in rpoS
transcription respond to intracellular
signals related to the cessation of
growth caused by environmental
stresses. The involvement of the
intracellular molecule, guanosine
3,5-bispyrophosphate (ppGpp), as a
positive signal of rpoS expression has
been reported (37). The barA gene
product, first identified as a regulator
of ompR (38), has been demonstrated
to induce rpoS transcription (39). A
two-component regulatory system
for anaerobiosis, ArcA/ArcB, is involved in modulation of rpoS
expression (10). The phospho-ArcA represses transcription of the
rpoS gene by directly binding to the rpoS promoter region.
Although the importance of CRP in the regulation of rpoS
genes has been reported in E. coli and S. enterica serovar Typhi-
murium (14, 11), the regulatory mechanism of rpoS transcrip-
tion by the cAMP-CRP complex requires further study. The
role of cAMP-CRP complex as an important negative transcrip-
tional regulator was proven only genetically via rpoS-fusion
assays using knock-out mutants unable to produce CRP or
cAMP (14, 16). Repression of rpoS transcription by cAMP-CRP
was also confirmed by the phenotype of a crr knock-outmutant
(15). EIIAglc, which is a crr gene product and a component of
the glucose uptake system, acts indirectly on the repression of
rpoS expression bymodulating the activity of adenylate cyclase.
However, the molecular basis of transcriptional modulation of
the rpoS gene by cAMP-CRP has not yet been identified in any
bacterial system.
Because rpoS transcription is quite different among bacterial
species (9), we examined the expression of the rpoS gene in V.
vulnificus at the level of transcription. We preliminarily ana-
lyzed the transcription units of the rpoS gene and found two
transcripts for rpoS,3 as occurred in E. coli (40). However, the
sizes of the V. vulnificus rpoS transcripts were distinct from
those of E. coli and other bacterial species (Fig. 8). In E. coli and
S. enterica, the rpoS gene is expressed as a polycistronic nlpD-
rpoSmRNA and an2.0-kb-long rpoSmonocistronic mRNA.
Polycistronic nlpD-rpoS mRNA originates from two closely
3 K.-J. Park and K.-H. Lee, unpublished data.
FIGURE 8. Genetic organization and expression of rpoS genes in some Gram-negative bacteria. The
genetic organization of rpoS and its upstream genes (nlpD, pcm, and surE) of V. vulnificuswere compared with
those of E. coli (14), S. enterica serovar Typhimurium (11), and P. putida (12). The transcription start sites for each
rpoSgene aredesignatedwitharrows, and thebinding site locations for transcription factors aredesignatedby
vertical lineswith thenameofeach transcription factor. In thecaseofE. coliandS. enterica, CRP-binding sites are
putative and are thus designated with question marks.
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spaced promoters upstream of the nlpD gene. The second pro-
moter responsible for monocistronic rpoS mRNA is located
within the nlpD gene, which had been identified as amajor rpoS
promoter (41). In E. coli growing in LB medium, the polycis-
tronic nlpD-rpoS mRNA was constitutively expressed, but the
monocistronic rpoSmRNA was induced only at the stationary
phase (14). In the case of P. putida rpoS, a single promoter
located within the nlpDORF was identified (Fig. 8).
Primer extension experiments identified a transcription ini-
tiation site 29 bp upstream of the rpoSORF and another initia-
tion site for a larger transcript at473 with respect to the IC of
V. vulnificus rpoS (Fig. 1, A and B). Thus, a shorter rpoS tran-
script of 1,021 bp was detected in addition to a 1,518-bpmono-
cistronic rpoSmRNA inV. vulnificus. The series of rpoS::luxAB
fusions indicated that the promoter located within the nlpD
gene (Pd) is a major promoter, as shown in other bacteria (Fig.
2). In contrast, the promoter located just upstream of the rpoS
(Pp) is a minor factor for rpoS expression. Expression of both
promoters was induced as the cells entered the stationary phase
in LBS medium. However, the affinity of each promoter to the
cAMP-CRP complex was quite different (Fig. 5, C and D, and
Fig. 6C), which might suggest each promoter has a differential
role in V. vulnificus in response to specific stresses. Therefore,
further investigation of the roles of each promoter is required to
understand its relative contribution to rpoS gene expression
under various conditions. Unlike E. coli, the upstream region of
nlpD is not involved in rpoS expression, because luciferase
activities of two fusions containing the upstream regions of
nlpD (pKP-1315 and pKP-1640) were similar to those of two
fusions without the nlpD upstream region (pKP-732 and pKP-
891) (Fig. 2). This further implies that nlpD transcription in V.
vulnificus may start at the further upstream region of the pcm
or surE genes.
RpoS levels of V. vulnificus were inversely correlated to the
intracellular concentrations of cAMP; for example, stationary
phase cells grown in complexmedia, such as LBSmedium, con-
tained less cAMP (5 fmol of cAMP/g of bacterial protein)
than exponential phase cells (50 fmol of cAMP/g of bacte-
rial protein) (Fig. 3). This pattern of intracellular cAMP fluctu-
ation was similar to that shown in E. coli cells grown in LB
medium (42). The role of cAMP-CRP in rpoS transcription was
confirmed in various V. vulnificus strains, in which CRP was
knocked out or the synthesis/degradation of cAMPwas altered
(Table 3). Expression of rpoS fusions was decreased in the
cpdA mutant that has an intracellular cAMP level approxi-
mately twice that estimated in its isogenic wild type strain. rpoS
expression was highly increased in the crp and cya mutants
but decreased in the cya mutant in the presence of exog-
enously added cAMP (Table 3 and Fig. 4). Therefore, rpoS
expression is tightly dependent upon the cAMP-CRP complex
at the transcriptional level in V. vulnificus.
V. vulnificus growing in a glucose-based minimal medium,
such as artificial seawater supplemented with glucose as a sole
carbon source, contained significant cAMP levels when cells
entered the stationary phase because of carbon source depletion.4
In addition, E. coli cells grown in aminimal medium, such asM9
supplemented with glucose, did not show induction of rpoS
transcription during the stationary phase; cellular cAMP levels
were also highly increased during this phase (14). Thus, rpoS
transcription is highly repressed by cAMP-CRP complex under
this condition, and thus regulation at the post-transcriptional
level is important in the stationary phase induction of RpoS.
In this study, we further confirmed the role of the cAMP-
CRP complex in rpoS expression by demonstrating the repres-
sion of rpoS expression by addition of CRP to the in vitro tran-
scription reaction (Fig. 5) and the direct interaction of both
rpoS promoters with recombinant CRP protein (Fig. 6). The
interactions between the rpoS promoters and cAMP-CRP com-
plex are mediated by DNA sequences homologous to the CRP-
binding consensus sequence (Fig. 7A). Alteration of these puta-
tive CRP-binding sites resulted in the disappearance of specific
interaction with the cAMP-CRP complex in vitro (Fig. 7, B and
C) and abolishment of transcriptional repression by the cAMP-
CRP complex in vivo (Fig. 7, D and E). This is the first study
showing the direct interaction of the cAMP-CRP complex with
the rpoS promoters.
The data presented in this study do not exclude the possibil-
ity that other transcriptional factors are involved in rpoS
expression in V. vulnificus. The transcriptional fusions of rpoS
in cya and crp mutants still showed the induction of expres-
sion at the stationary phase (data not shown). This suggests that
the induction of rpoS transcription is partly controlled by
another factor, which is independent of cAMP and CRP. In
silico screening of the V. vulnificus genome suggests the
absence of a gene homologous to the transcriptional activator
PsrA found in Pseudomonas putida (12). Therefore, theremust
be other transcriptional factors in V. vulnificus that remain to
be elucidated in future studies.
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